You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer
|
|---|---|
| Published in |
Cancer Discovery, July 2022
|
| DOI | 10.1158/2159-8290.cd-21-1026 |
| Pubmed ID | |
| Authors |
Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi, Raymone Pajarillo, Christopher Tor Sauter, Ruchi Patel, Hatcher J. Ballard, Seok Jae Hong, Inkook Chun, Nicholas Yang, Kimberly V. Amelsberg, Katherine D. Cummins, Jakub Svoboda, Saar Gill, Elise A. Chong, Khrystyna North, Sarah E. Church, Joseph A. Fraietta, Wan-Jung Chang, Simon F. Lacey, Xueqing Maggie Lu, Yunlin Zhang, Kanupriya Whig, David C. Schultz, Sara Cherry, James Gerson, Stephen J. Schuster, Patrizia Porazzi, Marco Ruella |
X Demographics
The data shown below were collected from the profiles of 97 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 44 | 45% |
| Canada | 2 | 2% |
| Spain | 2 | 2% |
| France | 2 | 2% |
| Germany | 2 | 2% |
| India | 1 | 1% |
| Pakistan | 1 | 1% |
| Singapore | 1 | 1% |
| Russia | 1 | 1% |
| Other | 10 | 10% |
| Unknown | 31 | 32% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 45 | 46% |
| Scientists | 40 | 41% |
| Science communicators (journalists, bloggers, editors) | 6 | 6% |
| Practitioners (doctors, other healthcare professionals) | 6 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 48 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 7 | 15% |
| Student > Ph. D. Student | 7 | 15% |
| Other | 6 | 13% |
| Student > Master | 5 | 10% |
| Unspecified | 3 | 6% |
| Other | 5 | 10% |
| Unknown | 15 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 9 | 19% |
| Immunology and Microbiology | 9 | 19% |
| Medicine and Dentistry | 6 | 13% |
| Unspecified | 3 | 6% |
| Nursing and Health Professions | 1 | 2% |
| Other | 2 | 4% |
| Unknown | 18 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 72. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2023.
All research outputs
#603,282
of 25,759,158 outputs
Outputs from Cancer Discovery
#312
of 4,155 outputs
Outputs of similar age
#14,833
of 433,981 outputs
Outputs of similar age from Cancer Discovery
#11
of 108 outputs
Altmetric has tracked 25,759,158 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,155 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.1. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,981 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.